Pilot and Translational Study of Dasatinib (NSC#732517) Paclitaxel and Carboplatin in Women With Advanced Stage and Recurrent Endometrial Cancer

Trial Profile

Pilot and Translational Study of Dasatinib (NSC#732517) Paclitaxel and Carboplatin in Women With Advanced Stage and Recurrent Endometrial Cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs Dasatinib (Primary) ; Carboplatin; Paclitaxel
  • Indications Endometrial cancer
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 10 Jul 2017 Planned End Date changed from 1 Jul 2015 to 1 Dec 2017.
    • 22 Dec 2015 Planned End Date changed from 1 Jun 2014 to 1 Jul 2015, according to ClinicalTrials.gov record.
    • 22 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Jul 2015, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top